Maypharm announces new product METOX in Times Square, New York

Seoul, South Korea, and New York, Jan. 28 / PRNewswire / Maypharm announces new botulinum toxin, METOX on January 26, 2021. METOX is an effective solution for smoothing all types of wrinkles, from moderate to severe, caused by daily active facial movements.

Maypharm is focused on outstanding pharmaceutical products to offer superior botulinum toxin products with a current technological edge and a sophisticated, advanced quality system for manufacturing and sophisticated equipment to meet the GMP requirements of the agency’s CGMP regulations.

Maypharm has successfully entered the toxin market, announcing its own newly launched toxin on the Times Square Spectacular digital billboard in New York.

Maypharm already has wholesale partners all over the world in China, Russia, Europe, the USA, the Middle East and West Asian countries and regions (Taiwan, Thailand, Vietnam, Philippines), so it is now intended to introduce METOX, a new toxin worldwide deliver and achieve a strong position in the European market and significantly increase the toxin’s market share within three years of product launch.

METOX is currently actively conducting clinical trials in various fields to treat symptoms such as jaw asymmetry and shoulder muscle pain, in addition to indications in areas such as the improvement of glabellar lines and wrinkles around the eyes.

All existing botulinum toxins are produced in the traditional way – by lyophilization, whereby a certain amount of powder remains on the bottom of each ampoule. In the meantime, METOX 100U botulinum toxin A uses a second generation technology, a further developed technique known as vacuum dehydration. As a result, almost no powder residue remains on the bottom of the ampoule. It minimizes denaturation such as foam or broken molecules when diluting, which makes the penetration process almost painless and filling with a syringe much easier (due to the absence of air).

Read Also:  Deconfining the red departments? "Pure madness" for the president of Bas-Rhin

Research has shown that the development of METOX, based on the latest equipment and new standards in research and development and due to the technology of the 2nd generation, compared to other products, has a main advantage in the high purity, the stabilizing effect and the has proven effectiveness, which not only means safe, high-quality procedures with perfect results, but also sets an absolutely new level in the global botulinum toxin market.

For more information, see www.maypharm.net

Contact via maypharm@maypharm.co.kr

Photos – https://mma.prnewswire.com/media/1423400/1st_photo_Metox_image.jpg

Photos – https://mma.prnewswire.com/media/1423908/METOX_small.jpg

Inquiries & contact:

Kiko lee
+82-2-6933-6086

.

Share on facebook
Facebook
Share on pinterest
Pinterest
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Trending